Green tea catechins and blood pressure: A systematic review and meta-analysis of randomised controlled trials

European Journal of Nutrition

Volumn 53, Issue 6, 2014, Pages 1299-1311

  Khalesi, Saman ^a   Sun, Jing ^a,b   Buys, Nicholas ^a   Jamshidi, Arash ^c,d   Nikbakht Nasrabadi, Elham ^a   Khosravi Boroujeni, Hossein ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Supplementary Medicine Department Sondos Teb Co   (Iran)

Author keywords

Blood Pressure; Green tea; Lipid profile; Meta analysis; Systematic review

Indexed keywords

CATECHIN; GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TEA;

BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TEA; VASCULAR DISEASE; BLOOD; CHEMISTRY; DRUG EFFECTS; FACTUAL DATABASE; SENSITIVITY AND SPECIFICITY;

SCOPUS;

BLOOD GLUCOSE; BLOOD PRESSURE; CATECHIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DATABASES, FACTUAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; TEA;

EID: 84906934265     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0720-1     Document Type: Review

References (56)

1. WHO (2002) World Health Organization. World Health Report 2002. Reducing risks, promoting healthy life. Geneva, Switzerland. http://wwww.hoint/whr/2002/ en
2. WHO (2008) Global health observatory (GHO). Raised blood pressure. http://www.who.int/gho/ncd/risk-factors/blood-pressure-prevalence-text/en/index. html
3. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS (2012) Heart disease and stroke statistics - 2012 update a report from the American Heart Association. Circulation 125(1):e2-e220
4. Law M, Wald N, Morris J (2005) Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Int J Technol Assess Health Care 21(1):145. doi:10.1017/s0266462305220196
5. Qureshi A, Sapkota B (2011) Blood pressure reduction in secondary stroke prevention. Continuum (Minneapolis, Minn) 17 (6 2ndary Stroke Prevention):1233
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206-1252 (Pubitemid 37553153)
7. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A (2008) Flavonoids, flavonoidrich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88(1):38-50 (Pubitemid 351988681)
8. Rains TM, Agarwal S, Maki KC (2011) Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22(1):1-7
9. Balentine DA, Wiseman SA, Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37(8):693-704 (Pubitemid 127349613)
10. Bhardwaj P, Khanna D (2013) Green tea catechins: defensive role in cardiovascular disorders. Chin J Nat Med 11(4):345-353
11. Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G (2005) Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem 16(3):144-149. doi:10.1016/j.jnutbio.2004.11.006 (Pubitemid 40312166)
12. Maruyama K, Iso H, Sasaki S, Fukino Y (2009) The association between concentrations of green tea and blood glucose levels. J Clin Biochem Nutr 44(1):41
13. Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, Setiawan VW, Zhou XF, Ding BG, Wang RH (2005) Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 116(6):972-983 (Pubitemid 41209206)
14. Sun C-L, Yuan J-M, Koh W-P, Mimi CY (2006) Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27(7):1310-1315 (Pubitemid 43985405)
15. Antonello M, Montemurro D, Bolognesi M, Di Pascoli M, Piva A, Grego F, Sticchi D, Giuliani L, Garbisa S, Rossi GP (2007) Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 20(12):1321-1328 (Pubitemid 350151690)
16. Nagao T, Hase T, Tokimitsu I (2007) A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 15(6):1473-1483. doi:10.1038/oby.2007.176 (Pubitemid 47110911)
17. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanidkulchai B-O, Auvichayapat N, Thinkhamrop B, Kunhasura S, Wongpratoom S, Sinawat S, Hongprapas P (2008) Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol Behav 93(3):486-491 (Pubitemid 351208430)
18. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264-269
19. Liberati A, Moher D, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. doi:10.1371/journal.pmed.1000100
20. Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health 52(6):377-384 (Pubitemid 28438523)
21. Cohen J (1992) A power primer. Psychol Bull 112(1):155-159. doi:10.1037/0033-2909.112.1.155
22. Harrison RA, Siminoski K, Vethanayagam D, Majumdar SR (2007) Osteoporosis-related kyphosis and impairments in pulmonary function: a systematic review. J Bone Miner Res 22(3):447-457 (Pubitemid 46797128)
23. Higgins J, Green SP, Wiley I, Cochrane C (2008) Cochrane handbook for systematic reviews of interventions. vol Book, Whole. Wiley-Blackwell, Hoboken
24. Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Medical Research Council, UK
25. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188. doi:10.1016/0197-2456(86)90046-2 (Pubitemid 17189972)
26. Kim A, Chiu A, Barone MK, Avino D, Wang F, Coleman CI, Phung OJ (2011) Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc 111(11):1720-1729
27. Dong J-Y, Szeto IM, Makinen K, Gao Q, Wang J, Qin L-Q, Zhao Y (2013) Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 110(07):1188-1194
28. Sone T, Kuriyama S, Nakaya N, Hozawa A, Shimazu T, Nomura K, Rikimaru S, Tsuji I (2011) Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr Res 55:1-10. doi:10.3402/fnr.v55i0.8326
29. Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, Wu M, Aston CE, Lyons TJ (2011) Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27(2):206-213. doi:10.1016/j.nut. 2010.01.015
30. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H (2005) Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) 51(5):335-342 (Pubitemid 41727426)
31. Bogdanski P, Suliburska J, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A (2012) Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res 32(6):421-427. doi:10.1016/j.nutres.2012.05.007
32. Frank J, George TW, Lodge JK, Rodriguez-Mateos AM, Spencer JP, Minihane AM, Rimbach G (2009) Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr 139(1):58-62. doi:10.3945/jn.108.096412
33. Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P (2011) Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev 16(2):157-163
34. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P (2008) Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27(3):363-370
35. Nagao T, Hase T, Tokimitsu I (2007) A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 15(6):1473-1483. doi:10.1038/oby.2007.176 (Pubitemid 47110911)
36. Nantz MP, Rowe CA, Bukowski JF, Percival SS (2009) Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 25(2):147-154
37. Suliburska J, Bogdanski P, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A (2012) Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res 149(3):315-322. doi:10.1007/s12011-012-9448-z
38. Vieira Senger AE, Schwanke CHA, Gomes I, Valle Gottlieb MG (2012) Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. J Nutr Health Aging 16(9):738-742. doi:10.1007/s12603-012- 0081-5
39. Diepvens K, Kovacs EM, Nijs IM, Vogels N, Westerterp-Plantenga MS (2005) Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females. Br J Nutr 94(6):1026-1034 (Pubitemid 43092437)
40. Chantre P, Lairon D (2002) Recent findings of green tea extract AR25 (exolise) and its activity for the treatment of obesity. Phytomedicine 9(1):3-8 (Pubitemid 34184203)
41. Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH (1995) Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 155(7):701-709. doi:10.1001/archinte.1995.00430070053006
42. Islam MA (2012) Cardiovascular effects of green tea catechins: progress and promise. Recent Pat Cardiovasc Drug Discov 7(2):88-99
43. Rastaldo R, Pagliaro P, Cappello S, Penna C, Mancardi D, Westerhof N, Losano G (2007) Nitric oxide and cardiac function. Life Sci 81(10):779-793 (Pubitemid 47332516)
44. Gössl M, Lerman A (2006) Endothelin beyond a vasoconstrictor. Circulation 113(9):1156-1158
45. Collins QF, Liu H-Y, Pi J, Liu Z, Quon MJ, Cao W (2007) Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. J Biol Chem 282(41):30143-30149 (Pubitemid 350035266)
46. Pon Anandh B, Dongmin L (2008) Green tea catechins and cardiovascular health: an update. Curr Med Chem 15(18):1840-1850. doi:10.2174/ 092986708785132979
47. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J (2003) Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 163(12):1448-1453 (Pubitemid 36758917)
48. Koo SI, Noh SK (2007) Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18(3):179-183 (Pubitemid 46216812)
49. Bursill CA, Abbey M, Roach PD (2007) A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193(1):86-93 (Pubitemid 46783905)
50. Ikeda I, Kobayashi M, Hamada T, Tsuda K, Goto H, Imaizumi K, Nozawa A, Sugimoto A, Kakuda T (2003) Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J Agric Food Chem 51(25):7303-7307
51. Hsu T, Kusumoto A, Abe K, Hosoda K, Kiso Y, Wang M, Yamamoto S (2006) Polyphenol-enriched oolong tea increases fecal lipid excretion. Eur J Clin Nutr 60(11):1330-1336 (Pubitemid 44669703)
52. Westerterp-Plantenga MS (2010) Green tea catechins, caffeine and body-weight regulation. Physiol Behav 100(1):42-46
53. Rains TM, Agarwal S, Maki KC (2011) Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22(1):1-7
54. Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VL, Heber D (2003) Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutr Cancer 45(2):226-235 (Pubitemid 37022797)
55. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23(5):921-928 (Pubitemid 40637906)
56. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJP, Bittner V, Fruchart J-C, Treating New Targets I, Treating to New Targets I (2007) HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357(13):1301-1310. doi:10.1056/NEJMoa064278 (Pubitemid 47481452)